Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Leukemia and FCGR3A[original query] |
|---|
| FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia. Blood 2005 Jan 105 (1): 289-91. Lin Thomas S, Flinn Ian W, Modali Rama, Lehman Teresa A, Webb Jennifer, Waymer Sharon, Moran Mollie E, Lucas Margaret S, Farag Sherif S, Byrd John |
| Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients. Medical mycology 2005 Jun 43 (4): 349-53. Choi Eun Hwa, Taylor James G, Foster Charles B, Walsh Thomas J, Anttila Veli-Jukka, Ruutu Tapani, Palotie Aarno, Chanock Stephen |
| Effect of FCGR2A and FCGR3A variants on CLL outcome. Blood 2010 Nov 116 (20): 4212-22. Dornan David, Spleiss Olivia, Yeh Ru-Fang, Duchateau-Nguyen Guillemette, Dufour Annika, Zhi Jianguo, Robak Tadeusz, Moiseev Sergey I, Dmoszynska Anna, Solal-Celigny Philippe, Warzocha Krzysztof, Loscertales Javier, Catalano John, Afanasiev Boris V, Larratt Loree, Rossiev Viktor A, Bence-Bruckler Isabelle, Geisler Christian H, Montillo Marco, Wenger Michael K, Weisser Mart |
| Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia. Annals of hematology 2016 Jul . Burkhardt Birgit, Yavuz Deniz, Zimmermann Martin, Schieferstein Jutta, Kabickova Edita, Attarbaschi Andishe, Lisfeld Jasmin, Reiter Alfred, Makarova Olga, Worch Jennifer, Bonn Bettina R, Damm-Welk Christi |
| Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group. Clinical pharmacokinetics 2017 06 56 (6): 635-647. Tout Mira, Gagez Anne-Laure, Leprêtre Stéphane, Gouilleux-Gruart Valérie, Azzopardi Nicolas, Delmer Alain, Mercier Mélanie, Ysebaert Loïc, Laribi Kamel, Gonzalez Hugo, Paintaud Gilles, Cartron Guillaume, Ternant Dav |
| FCGR3A F158V alleles frequency differs in multiple myeloma patients from healthy population. Oncoimmunology 2024 8 13 (1): 2388306. Michaël Constantinides, Nicolas Robert, Caroline Multrier, Loïs Coënon, Mauricio Campos-Mora, Carine Jacquard, Fei Gao, Sara Zemiti, Jessy Presumey, Guillaume Cartron, Jérome Moreaux, Martin Villal |
- Page last reviewed:Feb 1, 2024
- Content source: